These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 20056348

  • 1. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R, Wust P, Lopez-Hänninen E, Gademann G, Peters N, Berg T, Malfertheiner P, Ricke J.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):172-9. PubMed ID: 20056348
    [Abstract] [Full Text] [Related]

  • 2. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, Wieners G, Gaffke G, Kropf S, Felix R, Wust P.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):479-85. PubMed ID: 20304566
    [Abstract] [Full Text] [Related]

  • 3. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F, Lutter A, Schnapauff D, Hildebrandt B, Puhl G, Denecke T, Wust P, Gebauer B.
    Rofo; 2014 Jun 01; 186(6):606-12. PubMed ID: 24407711
    [Abstract] [Full Text] [Related]

  • 4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 5. CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis.
    Pech M, Wieners G, Kryza R, Dudeck O, Seidensticker M, Mohnike K, Redlich U, Rühl R, Wust P, Gademann G, Ricke J.
    Strahlenther Onkol; 2008 Jun 01; 184(6):302-6. PubMed ID: 18535805
    [Abstract] [Full Text] [Related]

  • 6. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
    Kolotas C, Tselis N, Sommerlad M, Röddiger S, Schnabel T, Baltas D, Kalogera-Fountzila A, Fountzilas G, Zamboglou N.
    Strahlenther Onkol; 2007 Feb 01; 183(2):69-75. PubMed ID: 17294110
    [Abstract] [Full Text] [Related]

  • 7. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.
    Peters N, Wieners G, Pech M, Hengst S, Rühl R, Streitparth F, Lopez Hänninen E, Felix R, Wust P, Ricke J.
    Strahlenther Onkol; 2008 Jun 01; 184(6):296-301. PubMed ID: 18535804
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R, Seidensticker M, Peters N, Mohnike K, Bornschein J, Schütte K, Amthauer H, Malfertheiner P, Pech M, Ricke J.
    Dig Dis; 2009 Jun 01; 27(2):189-99. PubMed ID: 19546558
    [Abstract] [Full Text] [Related]

  • 9. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
    Fusco V, Troiano M, Corsa P, Raguso A, Lioce M, Lauriola P, Parisi S.
    Radiol Med; 1998 Jun 01; 95(6):640-6. PubMed ID: 9717549
    [Abstract] [Full Text] [Related]

  • 10. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):472-8. PubMed ID: 16168839
    [Abstract] [Full Text] [Related]

  • 11. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T, Saito S, Toya K, Yorozu A, Dokiya T, Murai M.
    Int J Urol; 2006 Mar 01; 13(3):218-23. PubMed ID: 16643612
    [Abstract] [Full Text] [Related]

  • 12. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
    Farinati F, Rinaldi M, Gianni S, Naccarato R.
    Cancer; 2000 Dec 01; 89(11):2266-73. PubMed ID: 11147597
    [Abstract] [Full Text] [Related]

  • 13. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P, Dietrich J, Ostertag H, Schmid A, Kohr P, Kimmig B, Kovács G.
    Strahlenther Onkol; 2006 Feb 01; 182(2):102-7. PubMed ID: 16447017
    [Abstract] [Full Text] [Related]

  • 14. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
    Weitmann HD, Pötter R, Waldhäusl C, Nechvile E, Kirisits C, Knocke TH.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):468-78. PubMed ID: 15890589
    [Abstract] [Full Text] [Related]

  • 15. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 16. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):696-705. PubMed ID: 15183473
    [Abstract] [Full Text] [Related]

  • 17. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016
    [Abstract] [Full Text] [Related]

  • 18. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K, Khorprasert C, Rojpornpradit P, Chottetanaprasith T, Srisuthep A, Suriyapee S, Jumpangern C, Tresukosol D, Charoonsantikul C.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1424-31. PubMed ID: 15275728
    [Abstract] [Full Text] [Related]

  • 19. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
    Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, Pech M, Werk M, Rosner C, Hänninen EL, Freund T, Felix R.
    J Vasc Interv Radiol; 2004 Nov 01; 15(11):1279-86. PubMed ID: 15525748
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.